FOXO3 exhibited normal expression levels in normal liver tissues but was abnormally highly expressed in liver tissues of HCC patients, with further studies also confirming that FOXO3 contributed to the suboptimal disease-free survival and prognosis of HCC (Ahn et al., 2018; Song et al., 2020). Here, FOXO3 is linked to hepatocellular carcinoma.